chemoradiotherapy response
Showing 1 - 25 of >10,000
Relapse in Esophageal Squamous Cell Cancers Who Achieve PCR to
Active, not recruiting
- Esophageal Cancer
- follow up
-
Guangzhou, Guangdong, ChinaJianhua Fu
Sep 24, 2023
Locally Advanced Rectal Carcinoma Trial (Short course radiotherapy with concurrent capecitabine(825mg/m2), Long course
Not yet recruiting
- Locally Advanced Rectal Carcinoma
- Short course radiotherapy with concurrent capecitabine(825mg/m2)
- Long course radiotherapy with concurrent capecitabine(825mg/m2)
- (no location specified)
Jun 24, 2023
Rectal Cancer Trial in Rome (Repetition of Re-staging)
Recruiting
- Rectal Cancer
- Repetition of Re-staging
-
Rome, ItalyFondazione policlinico universitario a. gemelli IRCCS
Dec 20, 2021
Rectal Cancer, Chemoradiotherapy, Watch & Wait Trial in Seoul (Capecitabine)
Recruiting
- Rectal Cancer
- +2 more
-
Seoul, Korea, Republic ofKangbuk Samsung Hospital
Mar 30, 2022
Esophageal Cancer Trial in Groningen (Bevacizumab-IRDye800CW, Molecular Fluorescence Endoscopy platform)
Recruiting
- Esophageal Cancer
- Bevacizumab-IRDye800CW
- Molecular Fluorescence Endoscopy platform
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 19, 2022
Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Gastric Cardia Trial in
Active, not recruiting
- Adenocarcinoma of the Esophagus
- +5 more
- oxaliplatin
- +6 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jul 25, 2022
Predict nCRT Response in Locally Advanced Rectal Cancer
Completed
- Rectal Cancer
-
Guangzhou, Guangdong, China
- +2 more
May 1, 2021
Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New
Recruiting
- Locally Advanced Rectal Carcinoma
- +2 more
- Capecitabine
- +9 more
-
Gainesville, Florida
- +1 more
Jan 4, 2023
Cervix Uteri Cancer Trial in Tehran (Hypofractionated EBRT, Standard EBRT)
Recruiting
- Cervix Uteri Cancer
- Hypofractionated EBRT
- Standard EBRT
-
Tehran, Iran, Islamic Republic ofImam Khomeini Hospital Complex
Oct 11, 2021
Esophageal Cancer Trial in Daegu (chemoradiotherapy)
Recruiting
- Esophageal Cancer
- chemoradiotherapy
-
Daegu, Korea, Republic ofKyungpook National University Medical Canter
Aug 8, 2021
Nasopharyngeal Carcinoma, De-escalation Therapy Trial in Guangzhou (Cisplatin-based induction chemo, Full course of PD-1/PD-L1
Recruiting
- Nasopharyngeal Carcinoma
- De-escalation Therapy
- Cisplatin-based induction chemotherapy
- +4 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Oct 16, 2023
Oral Cancer, Induction Chemo, Programmed Cell Death 1 Inhibitor Trial in Shanghai (drug, procedure, radiation)
Active, not recruiting
- Oral Cancer
- +3 more
- Toripalimab
- +4 more
-
Shanghai, Shanghai, ChinaNinth People's Hospital, School of Medicine, Shanghai Jiao Tong
Nov 17, 2021
Immunological, Molecular-genetic, Image-based and Microbial
Recruiting
- Oncology
- +4 more
- Non-interventional
-
Munich, Bavaria, GermanyLMU University Hospital
Aug 31, 2021
Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (HB-201, HB-202, Carboplatin)
Recruiting
- Human Papilloma Virus
- +3 more
- HB-201
- +4 more
-
Chicago, IllinoisUniversity of Chicago
Aug 11, 2022
Cancer of Rectum Trial in Matosinhos (Analysis of cfDNA)
Recruiting
- Cancer of Rectum
- Analysis of cfDNA
-
Matosinhos, Porto, PortugalHospital Pedro Hispano
Aug 25, 2021
Tumor, Esophageal, Squamous Cell Carcinoma Trial in Guanzhou (drug, radiation, device)
Recruiting
- Neoplasm, Esophageal
- Squamous Cell Carcinoma
- Paclitaxel
- +6 more
-
Guanzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 21, 2021
Head Neck Cancer Trial in Sacramento (Induction Chemotherapy followed by Response Adapted Chemoradiation)
Completed
- Head and Neck Cancer
- Induction Chemotherapy followed by Response Adapted Chemoradiation
-
Sacramento, CaliforniaUniversity of California Comprehensive Cancer Center
Feb 24, 2021
Neoadjuvant Chemoradiotherapy for Esophageal Cancer
Completed
- Esophageal Cancer
- MRI and PET-CT
-
Houston, Texas
- +1 more
Nov 13, 2020
Non Small Cell Lung Cancer Stage III, Immunotherapy Trial in Hasselt, Amsterdam, Leiden
Not yet recruiting
- Non Small Cell Lung Cancer Stage III
- Immunotherapy
-
Hasselt, Vlaanderen, BelgiumKristof Cuppens
Jan 14, 2021
HPV-Related Squamous Cell Carcinoma, HNSCC Trial in Chicago (drug, procedure, radiation)
Active, not recruiting
- HPV-Related Squamous Cell Carcinoma
- HNSCC
- nab-paclitaxel
- +12 more
-
Chicago, IllinoisUniversity of Chicago Medical Center
Nov 12, 2021
Neoadjuvant Chemoradiotherapy, Locally Advanced Rectal Cancer, Pathological Complete Response Trial in Roma (RT Dose escalation
Recruiting
- Neoadjuvant Chemoradiotherapy
- +2 more
- RT Dose escalation in LARC patients with an Early Regression Index > 13.1 at second week on nCRT
-
Roma, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Mar 22, 2021
Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer
Recruiting
- Esophageal Cancer
- +3 more
- MRI
- +3 more
-
Amsterdam, Netherlands
- +3 more
Nov 13, 2020
"Watch and Wait" After Neo-adjuvant Chemoradiotherapy for
Recruiting
- Rectal Cancer
-
Bergen, Norway
- +6 more
Dec 15, 2020
Novel Type of CT Scan to Assess Treatment Response During
Completed
- Non-small Cell Lung Cancer Stage III
-
Chicago, IllinoisRush University Medical Center
Jan 15, 2021
Rectal Cancer Trial in Sao Paulo (Rectal resection, Observation)
Terminated
- Rectal Cancer
- Rectal resection
- Observation
-
Sao Paulo, BrazilInstituto Do Câncer Do Estado de São Paulo
May 7, 2020